相关实验视频

Updated: Jan 16, 2026

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

抗脂胺/前列抗体识别了一种独特的ITP形式

Sofia Camerlo^1,2, Massimo Radin³, Giorgio Rosati¹

¹Department of Clinical and Biological Sciences University of Turin Turin Italy.

|October 6, 2025

概括

抗脂抗体 (aPL) 在一些免疫性血栓缩症 (ITP) 患者中被发现,这表明血栓缩症较轻,但血栓发生风险较高. 查aPL和抗脂/原素 (aPS/PT) 可能指导ITP治疗决策.

科学领域:

免疫学免疫学免疫学
血液学血液学血液学
类风湿病学类风湿病学

背景情况:

免疫性血栓缩 (ITP) 和抗脂综合征 (APS) 是具有重叠特征的自身免疫性疾病.
血小板缺血是ITP的一个关键特征,而APS则涉及血栓症和妊娠并发症.
一些ITP患者具有抗脂抗体 (aPL),一些APS患者表现出血栓细胞减小.

研究的目的:

调查aPL在ITP患者中的患病率和影响.
为了比较ITP和APS队列之间的aPL阳性和血小板计数.
评估 aPL 在 ITP 的临床影响,包括治疗策略.

主要方法:

在90名ITP患者和132名APS患者中分析了aPL.
经过评估的抗酸胺/前列血 (aPS/PT) 抗体.
患者组之间的血小板计数和治疗方法的比较.

主要成果:

18.3%的ITP患者是aPL阳性,12%的患者有aPS/PT抗体.
16%的APS患者患有血小板缩,其中71%为aPS/PT阳性.
在ITP中aPL阳性与较不严重的血小板缺血相关,但影响了治疗选择.

结论:

在ITP中对aPL和aPS/PT的查可以确定患有较轻微的血栓缩和血栓形成风险增加的患者.
这些发现可能会指导治疗决策,例如在血栓形成素受体激动剂和SYK抑制剂之间进行选择.

关键词:

抗脂综合征是一种抗脂综合征.免疫性血小板减少症.脂胺/蛋白质抗体的抗体

更多相关视频

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

相关概念视频

Immunoprecipitation

Immunoprecipitation

Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Phosphoinositides and PIPs

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...